Home >  News >  Industry >  Pharma News >  Kochi based Agappe...

Kochi based Agappe Diagnostics unveils covid test kit based on RT-LAMP technology

The test in this technology will be completed in 10 minutes and the accurate result will get in one hour.;

By - Ruchika Sharma
Published On 2020-11-01 04:45 GMT   |   Update On 2021-11-22 16:18 GMT
Advertisement

Kochi: Agappe Diagnostics Ltd, a Kochi-based medical devices manufacturer, is launching a new Covid-19 test kit based on RT-LAMP (Reverse Transcription Loop-mediated Isothermal Amplification) technology.

Agappe is the first company in India to get the clearance of (ICMR) and Central Drug Standards Control Organisation (CDSCO) for this technology. They will launch this on November 10. According to them, the test in this technology will be completed in 10 minutes and the accurate result will get in one hour.
Speaking to ANI, Thomas John, MD said, "During the Covid pandemic, we bring the new technology called Loop amplification method, LAMP technology for the Covid. Not only Covid, but we are also coming with the other parameters like Leptospirosis, Dengue, Malaria, Chikungunya and other infectious diseases. This is a very advanced technology and already presents in developed countries like Japan, Korea, the US, etc. This technology always gives very precise values and it takes very less time for detection."
Advertisement
Dr. DM Vasudevan said, "We are testing the Covid cases by RT-PCR method. That is the usual test that we are doing. There are certain difficulties for the RT-PCR. One is that it will take a long time to get the result. The actual test needs about six hours and it will take about 24 hours to get the result to the patient. Whereas in the new technique, we are introducing now that is called LAMP technique. Here the test is actually done within 10 minutes. And the patient will get result in one hour. That is the greatest advantage."
"The Second advantage is that the RT-PCR test is costly. Because it needs a bigger machine, it is actually a thermal cycler is required and therefore sophisticated machine is required. And therefore ultimately the cost will be enhanced. Whereas this particular technique is very simple test which can be done any laboratory. Ordinary water bath will be sufficient for this. And the cost of the test will be reduced. These are two major advantages," Vasudevan said.
He added, "One more technical advantage is that this particular newer technique is 100 percent accurate. The RT-PCR is that it is 85 percent results we can rely. This particular test has been validated by ICMR as well as the other agencies of Govt of India. LAMP technology has been validated in the world in the last 4 or 5 years. And it has come here today now." 


Tags:    
Article Source : ANI

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Comments Policy
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News

Lupin partners with Sandoz to market, commercialize Ranibizumab biosimilar across multiple regions

Intas Pharma, Accord signs agreement to buy Prothya Biosolutions

Gland Pharma secures USFDA okay for Norepinephrine Bitartrate in 5% Dextrose Injection Bags

UCPMP 2024: Govt Details Stricter Rules to Curb Gifts, Incentives from Pharma to Doctors

AIOCD Opposes Karnataka's Third-Party Pharmacy Inspection Plan, Warns of Legal, Data Risks

Sun Pharma's Phase IV Study on Dual Release Pantoprazole for GERD Gets CDSCO Panel Acceptance

Draft Rules Set to Regulate Online Sale of Addictive Painkillers, Psychotropic Drugs: Govt

GSK Gepotidacin accepted for priority review by USFDA for oral treatment of uncomplicated urogenital gonorrhoea